SwitchGear Providing Roche's FuGene HD Reagent | GenomeWeb

This article has been corrected to note that Fugent is the owner of the FuGene technology, not Roche as previously reported.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SwitchGear Genomics today announced it will distribute Fugent's FuGene HD transfection reagent.

The product will be offered by Switchgear as a standalone product, as well as part of the company's LightSwitch Transfection Optimization kit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.